1 - 5 of 689
2021, 1월 11일

Bruker at 39th Annual J.P. Morgan Healthcare Conference

Bruker drives customer success and profitable growth by enabling scientific discoveries and delivering high-performance analytical, life science, pharmaceutical and diagnostic solutions.

2021, 1월 7일

GHz-Class NMR Opens New Scientific Research Window for Discoveries and Novel Insights in Functional Structural Biology and Disease Biology

BILLERICA, Massachusetts – January 7, 2021 – Bruker Corporation today announced that three world-leading institutions are now accelerating their research into functional structural biology and human disease with new Bruker ultra-high field nuclear magnetic resonance (NMR) spectrometers installed in 2020.

2020, 12월 18일

Bruker Launches FluoroType® SARS-CoV-2/Flu/RSV PCR Panel in Europe with CE-IVD Mark

NEHREN, Germany – December 18th, 2020: Bruker Corporation today announced the launch of the FluoroType SARS-CoV-2/Flu/RSV winter four-plex PCR panel, which enables the sensitive and simultaneous detection of the SARS-CoV-2 virus, of both influenza A and B viruses, as well as of the respiratory syncytial virus (RSV). In the winter season, multiple viruses need to be differentiated in one assay to facilitate diagnosis and patient management.